• January 25, 2012
    DURHAM, N.C.--Pfizer Animal Health Global Poultry’s new in ovo vaccination device, which was officially unveiled at IPE, could help improve operations at smaller hatcheries, according to one of the device’s trial participants. Marciano Régis Tonus, agribusiness director of Frango Seva, in Pato Branco, Brazil, spent a month trialling the new Embrex® Inovoject® m, a semi-automated device designed specifically for hatcheries that do notmore...
  • November 14, 2011
    RALEIGH, N.C.--Some ag student out there has a big idea about how to promote ag. The Reach Teach Learn Project will make it happen. Hundreds of youth study on ag college campuses every day, passionate about agriculture and ready to tell their story. The Reach Teach Learn Project provides a vehicle for students to channel that passion into advocacy for agriculture. In its fourth year, the Reach Teach Learn Project—sponsored by Pfizermore...
  • November 7, 2011
    The benefits of in ovo vaccination are now within the reach of many more hatcheries worldwide, thanks to the development of a new compact device. Embrex* Inovoject* m is a semi-automated in ovo vaccination system from Pfizer Animal Health Global Poultry designed for those hatcheries that do not have a large enough footprint or throughput to justify the installation of a full-size Embrex Inovoject. The new device allows thesemore...
  • October 13, 2011
    MADISON, N.J.--Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and othermore...
  • June 8, 2011
    Madison, N.J.--Pfizer Inc.’s Alpharma LLC subsidiary has decided to suspend sales in the United States of 3-Nitroâ (Roxarsone), a feed medicine used primarily in poultry production. Pfizer is taking this action in response to a request by the U.S. Food and Drug Administration (FDA) based on a recent study by the Agency. This study used a new method of testing for very low levels of inorganic arsenic in poultry tissue. The study found that themore...
  • March 7, 2011
    Durham, NC--Pfizer Poultry Health has introduced a broader, diversified portfolio of products and services with the acquisition of Alpharma LLC as part of Pfizer’s acquisition of King Pharmaceuticals. With the acquisition of Alpharma, Pfizer Poultry Health now offers a wider portfolio of products and services than any other global poultry healthcare provider. “The integration expands Pfizer Poultry Health’s product portfolio andmore...
  • January 28, 2011
    RALEIGH, N.C.--Visitors to the VIV Asia 2011 exhibition in Bangkok in March will be able to see the new, expanded portfolio from Pfizer Poultry Health, including one of its fully automated in ovo injection devices. Though the company has a wide range of health solutions covering the major poultry production diseases, its focus is on the individual farm, says Hari Yethirajyam Prasad, Asia-Pacific Regional Marketing Directormore...
  • January 26, 2011
    RALEIGH, N.C.--Pfizer Poultry Health is offering U.S. poultry producers a new option to optimize protection against one of the poultry industry’s most costly diseases, coccidiosis. Inovocox® EM1 is specially formulated to fight coccidiosis - the intestinal parasitic disease with an annual estimated global economic impact exceeding $3 billion. The new formulation accompanies the vaccine Inovocox® - launched in early 2009more...
  • July 7, 2010
    NEW YORK--As the global dairy industry continues to raise the bar on milk quality, Pfizer Animal Health recognizes a need for easy access to resources to help producers improve their milk quality decision-making. As a result, the company has launched a new online resource —www.milkqualityfocus.com— offering technical and actionable information on mastitis management and milk quality. "We understand the challenges dairy producers facemore...
  • June 11, 2010
    NEW YORK--Pfizer Animal Health today furthered its commitment to safe food from cattle by announcing a global licensing agreement with Epitopix that will expand access to its conditionally licensed Escherichia Coli Bacterial Extract vaccine* to U.S. cattle producers this fall. “Pfizer Animal Health supports cattle producers’ continuing strides against harmful bacteria, often the most frequent causes of food borne illnesses inmore...